These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2311515)

  • 21. Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency?: A comparison with noninvasive exocrine pancreatic function tests.
    Schneider AR; Hammerstingl R; Heller M; Povse N; Murzynski L; Vogl TJ; Caspary WF; Stein J
    J Clin Gastroenterol; 2006 Oct; 40(9):851-5. PubMed ID: 17016144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic pancreatitis and exocrine insufficiency.
    Greenberger NJ
    Hosp Pract (Off Ed); 1985 Jan; 20(1A):33-45. PubMed ID: 3918051
    [No Abstract]   [Full Text] [Related]  

  • 23. [The diagnostic validity of non-invasive pancreatic function tests--a meta-analysis].
    Siegmund E; Löhr JM; Schuff-Werner P
    Z Gastroenterol; 2004 Oct; 42(10):1117-28. PubMed ID: 15508057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modified ALTAB test in the diagnosis of exocrine pancreatic insufficiency].
    Rageh W; Klugmann HJ; Schiedewitz W; Pohl A
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):307-16. PubMed ID: 3879216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic value of fecal elastase test in pancreatic exocrine deficiency].
    Czakó L; Takács T; Farkas G; Boda K; Lonovics J
    Orv Hetil; 1999 Aug; 140(34):1887-90. PubMed ID: 10502971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The commercially available ELISA for pancreatic elastase 1 based on polyclonal antibodies does measure an as yet unknown antigen different from purified elastase 1. Binding studies and clinical use in patients with exocrine pancreatic insufficiency.
    Hardt PD; Hauenschild A; Nalop J; Marzeion AM; Porsch-Ozcürümez M; Luley C; Sziegoleit A; Kloer HU
    Z Gastroenterol; 2003 Sep; 41(9):903-6. PubMed ID: 13130326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum paraaminobenzoic acid following the use of N-benzoyl-L-tyrosyl-paraaminobenzoic acid in the diagnosis of pancreatic insufficiency].
    Wolf C; Ehrig C; Brunner H
    Schweiz Med Wochenschr; 1981 Mar; 111(10):343-7. PubMed ID: 6971491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pancreatic duct antibodies and subclinical insufficiency of the exocrine pancreas in Sjögren's syndrome].
    D'Ambrosi A; Verzola A; Buldrini P; Vavalle C; Panareo S; Gatto S; La Corte R; Vicentini L; Boccafogli A; Scolozzi R
    Recenti Prog Med; 1998 Oct; 89(10):504-9. PubMed ID: 9842253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic enzyme therapy and gastrointestinal symptoms in patients with cystic fibrosis.
    Walkowiak J; Lisowska A
    J Pediatr; 2005 Dec; 147(6):870-1. PubMed ID: 16356455
    [No Abstract]   [Full Text] [Related]  

  • 30. Exocrine pancreatic function after recovery from necrotizing pancreatitis.
    Bozkurt T; Maroske D; Adler G
    Hepatogastroenterology; 1995 Feb; 42(1):55-8. PubMed ID: 7782037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus.
    Nunes AC; Pontes JM; Rosa A; Gomes L; Carvalheiro M; Freitas D
    Am J Gastroenterol; 2003 Dec; 98(12):2672-5. PubMed ID: 14687815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thr28, Nle31 CCK-9--an useful CCK analogue in stimulation tests of pancreatic exocrine function.
    Schusdziarra V; Classen M
    Z Gastroenterol; 1988 Dec; 26(12):762-6. PubMed ID: 3245254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of fat absorption and its diagnostic value in exocrine pancreatic insufficiency.
    Simpson JW; Doxey DL
    Res Vet Sci; 1983 Sep; 35(2):249-51. PubMed ID: 6635347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pancreatic insufficiency in chronic pancreatitis: not a one-way street].
    Lankisch PG
    Z Gastroenterol; 1994 May; 32(5):262-3. PubMed ID: 8073799
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnostic approach to the patient with chronic pancreatic disease and suspected pancreatic carcinoma.
    Greenberger NJ
    J Kans Med Soc; 1984 Feb; 85(2):53-5, 64. PubMed ID: 6726051
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of pancreatic diseases].
    Gross V
    Z Arztl Fortbild (Jena); 1986; 80(6):263-71. PubMed ID: 3716487
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis of chronic pancreatitis].
    Raue G; Mössner J
    Internist (Berl); 1998 Dec; 39(12):1301-2. PubMed ID: 10198839
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of the external secretory function of the pancreas with a peroral test using the chymotrypsin substrate 4-(N-acetyl-L-tyrosyl) aminobenzoic acid. A methodological study].
    Malis F; Fric P; Kasafírek E; Slabý J; Zvárová J
    Cas Lek Cesk; 1981 Aug; 120(34):1014-9. PubMed ID: 6974596
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of 60-minute blood p-aminobenzoic acid concentration in pancreatic function testing of dogs.
    Strombeck DR; Harrold D
    J Am Vet Med Assoc; 1982 Feb; 180(4):419-21. PubMed ID: 6977519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stages in the development of chronic pancreatitis].
    Münch R; Ammann RW
    Internist (Berl); 1989 Nov; 30(11):738-46. PubMed ID: 2691434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.